Back to results
US 2014/0193521 A1Published application
Drug Delivery Systems and Method of Reducing Foal Infection by Treating Mares with Gallium Salts
OwnerBenjamin R. Buchananinventor
Life of this patent
Estimating the term…
Abstract
This invention relates to drug delivery systems and methods of preventing respiratory bacterial infection in a foal of a mare. This invention relates to the reduction of transmission from the mare to the foal of bacteria though contaminated matter in the foal's environment.
Claims11
A drug delivery system for reducing the concentration of pathogenic bacteria in feces of a mare, the drug delivery system comprising:
- at least one gallium salt in a therapeutically effective amount and in a form that is substantially non-absorbable by a gastrointestinal system of the mare;
- the at least one specific said gallium salt has an effect of reducing the concentration of pathogenic bacteria in feces of the mare as compared to feces of the mare prior to receiving the at least one gallium salt;
- and
- a pharmaceutically acceptable carrier for delivering the at least one gallium salt to a natural orifice, throat or lungs of the mare.
1 more element
A drug delivery system for preventing respiratory bacterial infection in a foal of a mare, the delivery system comprising:
- at least one gallium salt in a therapeutically effective amount and in a form that is substantially non-absorbable by a gastrointestinal system of the mare,
- the at least one gallium salt has an effect of reducing a concentration of pathogenic bacteria present in feces of the mare as compared to feces of the mare prior to receiving the at least one gallium salt;
- and
- a pharmaceutically acceptable carrier for delivering the at least one gallium salt to a natural orifice, throat or lungs of the mare.
1 more element
A method of preventing infection in a foal of a mare, the method comprising
- administering to the mare a drug delivery system comprising
- at least one gallium salt in a therapeutically effective amount and in a form that is substantially non-absorbable by a gastrointestinal system of the mare;
- and
- a pharmaceutically acceptable carrier for delivering the at least one gallium salt to a natural orifice, throat or lungs of the mare, the drug delivery system has an effect of decreasing the concentration of R. equi in the mare's feces, and
- the drug delivery system is administered within a predetermined time range prior to an anticipated date of foaling for the mare.
2 more elements
Dependencies are inferred from the claim text.